IraSethWinerMDPhD

PubMed

• Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1).
  Ulka N Vaishampayan, Jameel Muzaffar, Ira Winer, Seth D Rosen, Christoper J Hoimes
  Journal for Immunotherapy of Cancer. 2024-11-20
• Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.
  Elisabeth Heath, Gregory Dyson, Jennifer R Ribeiro, Joanne Xiu, Kelsey Poorman
  Cancer Research Communications. 2024-10-01
• 6 citations
  Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
  Ayse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, Yuan Chang, Adrian Levine
  The Lancet. Oncology. 2024-05-01

Journal Articles

• Merkel cell carcinoma in a patient with noninvasive vulvar Paget's disease  
  Winer IS, Lonardo F, Johnson SC, Deppe G., Am J Obstet Gynecol, 3/30/2013
• Chemotherapy of vulvar cancer: A Review  
  Deppe G, Mert I, Belotte J, WinerIS, Wien KlinWochenschr, 3/1/2013
• Clinical and Pathologic Characteristics of Serous Carcinoma Confined to the Endometrium: A Multi-institutional Study  
  Seeman A, Mert I, Munkarah A, Bandyopadhyay S, Winer I, et al., Int J GynecolPathol, 3/1/2013
• Correlation of tumor size with other prognostic factors in uterine serous carcinoma: A large multi-institutional study  
  Winer IS, Mahdi HS, Bandyopadhyay S, et al., GynecolOncol, 2/1/2013
• F3-Targeted Cisplatin-Hydrogel Nanoparticles as an Effective Therapeutic that Targets Both Murine and Human Ovarian Tumor Endothelial Cells In vivo  
  Winer I, Wang S, Lee Y-E, Fan W, Gong Y, Buros-Ojeda D, Spahlinger G, Kopelman, Buckanovich RJ, Cancer Res., 11/1/2010
• A case of progressive mucinous ovarian cancer of low malignant potential responsive to biologic therapy with Bevacizumab  
  Winer I, Buckanovich RJ, Gynecol Oncol, 3/1/2010
• Bevacizumab for the Treatment of Non-ResectablePseudomyxomaperitonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential – A Comparison of Two Cases  
  Winer I, Buckanovich RJ, Case Rep Oncol, 1/1/2010
• Effective Expression of Small Interfering RNA in human cells  
  Paul C, Good P, Winer I, Engelke DR, Nature Biotechnology, 1/1/2009
• Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation  
  ChoKR,Fearon ER, Cancer Res., 1/15/2007
•  
  Winer I, Gonik, N., Fearon, E.R, JBC, 1/1/2006
• Expression of 12-Lipoxygenase as a biomarker for Melanoma Carcinogenesis  
  Winer I, Normolle DP, Shureiqi I, Sondak VK, Johnson T, Su L, Brenner DE., Melanoma Research, 1/1/2002
•  
  Kolligs FT, Nieman M, Winer I, Hu G, Van Mater D, Feng Y, Smith I, Wu R, Zhai Y, Cho K, Fearon ER, Cancer Cell, 1/1/2002
• Join now to see all

Books/Book Chapters

• Know Thy Place 
  Chapter: Jonathan Adams Allen 
  Winer IAnn Arbor: University of Michigan Press2000

Abstracts/Posters

• The significance of squamous vs. adenocarcinoma subtypes in early stage cervical carcinoma
  Winer I, Alvarado-Cabrero I, Seward S, Valencia-Cedillo R, Munkarah A, Ali-Fehmi R., American Association of Cancer Research Annual Meeting, 4/1/2013
• A multi-institutional clinic-pathologic study of USC without myometrial invasion
  Winer I, Semaan A,Mert I, Hayek K, Bandyopadhyay S, Nucci MR, Van de Vijver KK, Hussein Y, Alosh B, Oliva E, Ali-Fehmi R, International Gynecologic Cancer Society (IGCS),, 10/1/2012
• Activation of the unfolded protein response (UPR) by disulfiram in ovarian cancer cells: A novel therapeutic mechanism to overcome chemoresistance
  Winer et al., International Journal of Gynecological Cancer, 10/1/2012
• Histone deacetylase inhibition in ovarian cancer
  Winer et al., Gynecologic Oncology, 1/1/2008
• Vascular targeted cisplatin nanoparticles for ovarian cancer therapy
  Winer et al., Gynecologic Oncology, 1/1/2008
• 12-Lipoxygenase Expression in Human Pigmented Skin Neoplasia
  Winer et al., Proceedings of the American Association for Cancer Research, 1/1/2001
• Disufiram (Antabuse) Activates the Unfolded Protein Response to Overcome Chemoresistance in Ovarian Cancer Cells
  Winer et al., MSACOG Resident/Fellow Research Day
• Join now to see all